cytarabine has been researched along with Wallerian Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calderón-MartÃnez, D; Garavito, Z; Hurtado, H; Spinel, C | 1 |
| Borgeat, A; De Muralt, B; Stalder, M | 1 |
2 other study(ies) available for cytarabine and Wallerian Degeneration
| Article | Year |
|---|---|
Schwann cell-enriched cultures from adult human peripheral nerve: a technique combining short enzymatic dissociation and treatment with cytosine arabinoside (Ara-C).
Topics: Adolescent; Adult; Antimetabolites; Antimetabolites, Antineoplastic; Bromodeoxyuridine; Cell Culture Techniques; Cell Survival; Cytarabine; Enzymes; Fibroblasts; Humans; Middle Aged; Peripheral Nerves; S100 Proteins; Schwann Cells; Wallerian Degeneration | 2002 |
Peripheral neuropathy associated with high-dose Ara-C therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axons; Cytarabine; Electromyography; Electrophysiology; Female; Humans; Leg; Leukemia, Lymphoid; Muscles; Neurologic Examination; Peripheral Nervous System Diseases; Wallerian Degeneration | 1986 |